The Factors Affecting the Achievement of Glucose Monitor in the Patients on Diabetes

October 18, 2020 updated by: Taichung Veterans General Hospital

The Effects of Glucose Monitor on Patients With Diabetes

To assess the effect of glucose monitors on glucose control and cardiovascular risks.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The investigators will enroll patients with diabetes. The answered questionnaire and blood samples will be collected at baseline. After change the methods or frequency of glucose monitor, the blood samples will be collected again. The investigators will analyze the factors which may affect the glucose control after changes in methods of glucose monitor.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
      • Taichung, Taiwan, 407
        • Recruiting
        • Division of Endocrinology and Metabolism in Taichung Veterans General Hospital
        • Sub-Investigator:
          • I-Te Lee, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults with diabetes both in outpatient and inpatient

Description

Inclusion Criteria:

  • Adults with diabetes

Exclusion Criteria:

  • Incooperative patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose variability
Time Frame: 3 months
Data from continue glucose monitor system
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
brain-derived neurotrophic factor
Time Frame: 3 months
Biomarker of cognition
3 months
Orexin
Time Frame: 3 months
Biomarker of cognition
3 months
Renalase
Time Frame: 3 months
Biomarker of cognition
3 months
Vascular endothelial cell adhesion molecule 1
Time Frame: 3 months
Biomarker for inflammation
3 months
Health Literacy
Time Frame: 3 months
Questionnaire of health
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Taichung Veterans General Hospital

Investigators

  • Principal Investigator: I-Te Lee, MD,PhD, Taichung Veterans General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2019

Primary Completion (Anticipated)

December 31, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

January 11, 2019

First Submitted That Met QC Criteria

January 11, 2019

First Posted (Actual)

January 15, 2019

Study Record Updates

Last Update Posted (Actual)

October 20, 2020

Last Update Submitted That Met QC Criteria

October 18, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CG18308A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Not to share individual participant data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Decline

Clinical Trials on Continue glucose monitor system

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe